What is the patent expiration date for prucalopride succinate?
I don’t have enough provided information to state a specific patent expiration date for prucalopride succinate. Patent timelines depend on the exact patent family (and country/region), and the expiration date can differ across jurisdictions and between primary vs. secondary patents.
Which patents could affect “expiration” for prucalopride?
“Expiration date” can mean different things, such as:
- the expiration of the original active-ingredient (compound) patent,
- expiration of later patents (e.g., formulations, processes, or uses),
- loss of data exclusivity or regulatory exclusivity (which may occur separately from patent expiry),
- or the final date after any patent term adjustments and extensions.
Without the specific patent numbers and the target jurisdiction (e.g., US, EU, UK, Canada, etc.), a single expiration date can’t be stated reliably.
What I need to give you an exact date
Share either:
- the country/region you care about (for example, “US” or “EU”), and
- the patent number(s) you mean (or the product/brand reference you’re looking up),
and I can map the correct expiration date(s) to the relevant patent(s).
Why people often get different answers for the “same” drug
Different databases and articles may report different dates because they track different rights (patents vs. exclusivity) or different patent families. Also, a company may face continued protection from secondary patents even after the earliest compound patent expires.
Quick check questions
1) Which market do you mean: US, EU, UK, Canada, or another country?
2) Do you want the expiration of the compound patent, or the last blocking patent / exclusivity date for generic entry?
Sources
No sources were provided, so I can’t cite patent-expiration data.